Machine Learning-Driven and Smartphone-Based Fluorescence Detection for CRISPR Diagnostic of SARS-CoV-2

Aubin Samacoits1, Pattaraporn Nimsamer2, Oraphan Mayuramart2

  • 1Sertis Corporation, Bangkok 10110, Thailand.

ACS Omega
|February 8, 2021
PubMed
Summary

This study introduces a low-cost, smartphone-based COVID-19 diagnostic tool using CRISPR technology and machine learning. It offers rapid and accurate detection of SARS-CoV-2, crucial for controlling the pandemic.

Related Concept Videos